Tag: Medicare Part D
In July, the F.D.A. decided to revoke approval of Avastin, also called bevacizumab, because the F.D.A. said follow up studies had found the drug was not effective and had dangerous side effects.
According to a study done by the University of California, Los Angeles and the University of Plymouth in the U.K., many Medicare beneficiaries find it
The Medicare Part D plan is notorious for its so-called doughnut gap. The doughnut gap is the gap in coverage where beneficiaries generally start paying